Clinical trials in Stockholm – page 30

745 clinical trials in Stockholm, Sweden across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SwedenKliniska-Provningar.se

Stockholm at a glance

745

clinical trials

Research sites8

Quick filters

745 trials in Stockholm

Open in trial search

Parkinson's disease

Not yet recruiting

Montelukast Sodium for disease-modifying treatment in patients with mild‑moderate Parkinson’s disease: open‑label phase II extension study

Registered drugNo placebo

Montelukast Sodium for disease-modifying treatment in patients with mild‑moderate Parkinson’s disease: open‑label phase II extension study

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Montelukast Sodium
Sponsor:Karolinska University Hospital

Contact Research Centre

Cystic fibrosis

Not yet recruiting

Safety and Efficacy of VX-828, Deutivacaftor, and Tezacaftor in Adults with Cystic Fibrosis

Registered drug

Safety and Efficacy of VX-828, Deutivacaftor, and Tezacaftor in Adults with Cystic Fibrosis

Registered drug

Sweden

Participants:18–64 years · 65+ years
Sponsor:Vertex Pharmaceuticals Inc.

Contact Research Centre

Compulsive sexual behaviour

Not yet recruiting

Comparing cognitive behavioral therapy alone versus cognitive behavioral therapy combined with degarelix to prevent sexual offenses in patients with paraphilic disorders

Registered drug

Comparing cognitive behavioral therapy alone versus cognitive behavioral therapy combined with degarelix to prevent sexual offenses in patients with paraphilic disorders

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Degarelix
Sponsor:Vastra Gotalandsregionen

Contact Research Centre

Endometrial cancer+7

Not yet recruiting

A study to evaluate the safety of SGN-ALPV in patients with advanced solid tumors

InvestigationalNo placebo

A study to evaluate the safety of SGN-ALPV in patients with advanced solid tumors

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:SGN-ALPV
Sponsor:Seagen Inc.

Contact Research Centre

COVID-19

Not yet recruiting

Study of Intravenous Immunoglobulin Added to Standard Treatment for COVID-19 in Patients with Severely Weakened Immune System Due to B-cell Problems

Registered drugNo placebo

Study of Intravenous Immunoglobulin Added to Standard Treatment for COVID-19 in Patients with Severely Weakened Immune System Due to B-cell Problems

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Nirmatrelvir
Sponsor:Region Vaesterbotten

Contact Research Centre

Endocrine ophthalmopathy+1

Not yet recruiting

A study to test if atorvastatin can prevent eye disease in patients newly diagnosed with Graves' disease

Registered drugNo placebo

A study to test if atorvastatin can prevent eye disease in patients newly diagnosed with Graves' disease

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Atorvastatin
Sponsor:Region Skane

Contact Research Centre

Atrial fibrillation

Not yet recruiting

A Study of Semaglutide in Overweight or Obese Patients with Atrial Fibrillation Scheduled for Catheter Ablation to Improve Treatment Outcomes

Registered drugNo placebo

A Study of Semaglutide in Overweight or Obese Patients with Atrial Fibrillation Scheduled for Catheter Ablation to Improve Treatment Outcomes

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Karolinska University Hospital

Contact Research Centre

Analgesic therapy

Not yet recruiting

Comparing spinal morphine and epidural drug combination for pain relief in patients having open colorectal surgery

Registered drugNo placebo

Comparing spinal morphine and epidural drug combination for pain relief in patients having open colorectal surgery

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Fentanyl Citrate

Contact Research Centre

Tick-borne viral encephalitis

Not yet recruiting

Testing Remdesivir in Hospitalized Adult Patients with Tick-Borne Encephalitis to Measure Effects on Brain Cell Damage

Registered drug

Testing Remdesivir in Hospitalized Adult Patients with Tick-Borne Encephalitis to Measure Effects on Brain Cell Damage

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Mannitol
Sponsor:Region Stockholm – SLSO

Contact Research Centre

Fibromyalgia

Not yet recruiting

Study of rituximab for reducing pain in patients with fibromyalgia caused by autoantibodies

Registered drugNo placebo

Study of rituximab for reducing pain in patients with fibromyalgia caused by autoantibodies

Registered drugNo placebo

Sweden

Participants:18–64 years
Substances:Methylprednisolone
Sponsor:Region Stockholm – SLSO

Contact Research Centre

Rectal cancer

Not yet recruiting

A Study of Watchful Waiting After Chemotherapy and Radiotherapy Compared to Surgery for Patients with Early Rectal Cancer Using Capecitabine

Registered drugNo placebo

A Study of Watchful Waiting After Chemotherapy and Radiotherapy Compared to Surgery for Patients with Early Rectal Cancer Using Capecitabine

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Vastra Gotalandsregionen

Contact Research Centre

Aortic aneurysm

Not yet recruiting

Study of Carbon Dioxide versus Iodine Contrast in Patients with Abdominal Aortic Aneurysm Having Fenestrated Endovascular Repair

Registered drugNo placebo

Study of Carbon Dioxide versus Iodine Contrast in Patients with Abdominal Aortic Aneurysm Having Fenestrated Endovascular Repair

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Iodixanol
Sponsor:Region Skane

Contact Research Centre

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Stockholm

What the registry says about research in the country

01 Oncology Research

Clinical trials focusing on metastatic prostate cancer and advanced breast cancer treatments, evaluating new therapeutic approaches and drug combinations.

Prostate Cancer Therapies
Breast Cancer Treatments
Colorectal Cancer Studies

Innovative research comparing various treatment protocols and investigating survival outcomes.

02 Infectious Diseases

Studies evaluating vaccines and treatments for respiratory syncytial virus, herpes zoster, and HPV infections.

Vaccine Development
Viral Disease Prevention
Immunization Studies

Focus on prevention and immune response in various age groups.

03 Cardiovascular Health

Research on heart failure prevention and hypertrophic cardiomyopathy, testing new therapeutic combinations.

Cardiac Arrest Management
Heart Failure Prevention
Cardiomyopathy Treatment

Emphasis on improving patient outcomes and testing novel drug combinations.

04 Neurological Disorders

Trials investigating treatments for Parkinson's disease and multiple sclerosis, focusing on disease progression and symptom management.

Disease Modification
Symptom Management
Treatment Efficacy

Studies evaluating both novel and existing therapeutic approaches.

05 Metabolic Conditions

Research on obesity and type 2 diabetes treatments, evaluating new medications for weight management.

Weight Management
Diabetes Control
Metabolic Health

Focus on lifestyle interventions combined with pharmaceutical approaches.

Back to Sweden All countries